SSSSSSSSSSSSSSSH be very very quiet and listen for the

New Post Public Reply Private Reply Replies (0) Message Board
wrenchman
621
SSSSSSSSSSSSSSSH be very very quiet and listen for the UNISHIMA BLAST oh yeah!;-)
KAAAAAAAAAAAAAAAAAAAAAAAAABOOM!

#CLINICALTRIALS
#CEOof2019

#MUGA
MAKING
UNIVEC
GREAT
AGAIN


$UNVC/MERCK/MARIMED/HARVEST/SATIVEO/AGRIMED/VA/FACEBOOK/WALMART/RITEAID/WELLNESSTELEDOC
ALL TO $5.00PLUS


https://www.newswire.com/news/detailed-study-...s-pipeline

Quote:
Detailed Study of the Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2016

PRESS RELEASE  DEC 26, 2016

December 26, 2016 (Press Release) - Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Transdermal Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2016

Scope

- Extensive coverage of the Transdermal Drug Delivery under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transdermal Drug Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Transdermal Drug Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned

3M Company Aequus Pharmaceuticals Inc Agile Therapeutics Inc Allergan Plc Alliqua BioMedical Inc Altea Therapeutics Corporation Anterios Inc Apogee Technology Inc Avro Life Sciences Axxia Pharmaceuticals, LLC Burke Pharmaceuticals LLC Carbylan Therapeutics Inc Cerimon Pharmaceuticals, Inc. Corium International Inc DBV Technologies SA Dermisonics, Inc. Dharma Therapeutics, Inc. DURECT Corp Echo Therapeutics Inc Exploit Technologies Pte Ltd Extend Biosciences Inc EyeGate Pharmaceuticals Inc Fe3 Medical Inc FluGen Inc French National Institute of Health and Medical Research Hisamitsu Pharmaceutical Co Inc ImmuPatch Imperial College London Indian Institute of Technology Bombay Intercell AG Interstitial NS Isis Biopolymer, Inc. Janisys Massachusetts Institute of Technology Meda AB Medherant Ltd MEDRx Co., Ltd mesoestetic USA Inc Micropoint Technologies Pte Ltd National Taiwan Ocean University NeuroDerm Ltd Nitto Denko Corp North Carolina State University Novosanis NV Nuvo Pharmaceuticals Inc Old Dominion University Pantec Biosolutions AG Phosphagenics Ltd Purdue University Radius Health Inc Ratio Inc Scilex Ltd Sensile Medical AG Skinject Inc Solasia Pharma KK Sparsha Pharma International Pvt Ltd Sparsha Pharma USA Inc Stanford University Sumitomo Dainippon Pharma Co Ltd Syntropharma Ltd Teikoku Seiyaku Co Ltd tesa Labtec GmbH Teva Pharmaceutical Industries Ltd TheraJect Inc TheraSolve NV Theratech, Inc. Titan Pharmaceuticals Inc Transcu Group Limited Transdermal Delivery Solutions Corp TransPharma Medical Ltd Transport Pharmaceuticals Inc Univec, Inc. University of Illinois at Chicago University of Toronto Vyteris, Inc. Zambon Italia Srl Z-Cube Srl Zosano Pharma Corp Zynerba Pharmaceuticals Inc



[chart]investorshub.advfn.com/uimage/uploads/2017/7/25/xefg[tenor.gif[/chart]

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
info_152_photo0_67668_big.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 55

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 39

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

Amicus Therapeutics Plans Third Quarter 2025 Earnings Call

Updated Category News Views 159

Amicus Therapeutics to Discuss Q3 2025 Financial Results Amicus Therapeutics (NASDAQ: FOLD) is preparing for an important financial discussion as it will host a conference call on November 4, 2025, at 8:30 a.m. ET. This call aims to provide insights into the company’s financial performance for the quarter ending September 30, 2025. Conference Call Participation...

Continue Reading
Cineplex Inc. Hits New Milestones In Q2 2025 Financials

Updated Category News Views 223

Cineplex Reports Impressive Growth in Second Quarter Financials Cineplex Inc. (TSX: CGX) has announced its financial performance for the second quarter of 2025, revealing remarkable growth across various metrics. The company’s total revenues surged to CAD 361.8 million, representing a robust 30.5% increase compared to the same period last year. This performance can be...

Continue Reading
Pinnacle Mergers & Acquisitions Finalizes $151M Deal with Dream Motor Group

Updated Category News Views 545

Pinnacle Mergers & Acquisitions Completes a Major Sale DALLAS — Pinnacle Mergers & Acquisitions, a premier automotive buy-sell advisory firm, has finalized the significant sale of Toyota of Montgomery and Lexus of Montgomery to the renowned Dream Motor Group, led by famed coach Nick Saban and automotive expert Joe Agresti. The deal is valued at an impressive $151...

Continue Reading
Atria Development Corporation Appoints New Vice President

Updated Category News Views 80

Atria Development Corporation Welcomes New Leadership Atria Development Corporation is thrilled to announce that Durval Terceira has been appointed as the new Vice President of Business Development and Labour Relations. With his impressive background, he brings a wealth of experience that is expected to steer the company towards its future goals. Durval Terceira: An...

Continue Reading
Ark Invest's Strategic Shift: Selling Block Inc. Shares

Updated Category News Views 289

Ark Invest Adjusts Its Strategy Cathie Wood's Ark Invest has recently made headlines by selling off a portion of its holdings in Block Inc. This decision, valued at an impressive $4.8 million, signifies a potential shift in investment strategy ahead of Block's forthcoming earnings report. Investors are closely monitoring this move as it coincides with Block's rising...

Continue Reading